VRICAN is a specialist medical practice in Diest. Private Limited, started on 15 December 2005, 1 establishment.

What is the address of VRICAN?

The registered office of VRICAN is located at Refugiestraat 2, 3290 Diest.

Is VRICAN still active?

Yes. According to the CBE (15 November 2026) VRICAN is active, legal situation “Normale toestand”, started on 15 December 2005.

Is VRICAN registered on Peppol?

Yes, VRICAN is registered on the Peppol network with ID 0208:0878611053.

What is the enterprise number of VRICAN?

The enterprise number of VRICAN is BE0878611053.

When was VRICAN founded?

VRICAN was founded on 15 December 2005.

Who are the directors of VRICAN?

According to the 2025 annual accounts, the directors of VRICAN are: David Van Roosbroeck.

Is VRICAN a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 15 December 2005; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account; 2 events from the Belgian Official Gazette processed.

How much profit did VRICAN make in 2025?

VRICAN posted a profit after taxes of € 145,638 in financial year 2025.

What is the revenue of VRICAN?

As a small company, VRICAN is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 207,095.

VRICAN (Private Limited) - Diest - BE0878611053

Dossier VRICAN, printed on 15 November 2026 from databakkes.be/en/0878611053/vrican. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

VRICAN from Diest, company number BE0878611053, closed financial year 2025 with a result of € 145,638 after tax. For that financial year VRICAN recorded a gross margin of € 207,095 and equity of € 652,568. Compared with financial year 2024, the result moved from € 142,885 to € 145,638. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on September 30, 2026.

What it is worth Growing

€ 652,568

▲ 11% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 145,638

▲ 2% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 139,184

▼ 65% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 82,751 paid out

57 % of the profit went to the shareholders, the rest stayed in the company.

People and assets in 2025

Vehicles and equipment

€ 2,870

▼ 13% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt

€ 3,361

Loans from banks and other lenders, long and short.

Owed to suppliers

€ 999

▼ 94% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 41,984

▲ 13% vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Key figures per fiscal year
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 147,806 Gross margin 2022: € 147,806 First fiscal year in the series	€ 174,337 Gross margin 2023: € 174,337 ▲ 18% vs 2022 (€ 147,806) Favourable step	€ 203,958 Gross margin 2024: € 203,958 ▲ 17% vs 2023 (€ 174,337) Favourable step	€ 207,095 Gross margin 2025: € 207,095 ▲ 2% vs 2024 (€ 203,958) Favourable step	▲ 2%
Profit after taxes	€ 93,766 Profit after taxes 2022: € 93,766 First fiscal year in the series	€ 122,911 Profit after taxes 2023: € 122,911 ▲ 31% vs 2022 (€ 93,766) Favourable step	€ 142,885 Profit after taxes 2024: € 142,885 ▲ 16% vs 2023 (€ 122,911) Favourable step	€ 145,638 Profit after taxes 2025: € 145,638 ▲ 2% vs 2024 (€ 142,885) Favourable step	▲ 2%
Equity	€ 460,730 Equity 2022: € 460,730 First fiscal year in the series	€ 583,642 Equity 2023: € 583,642 ▲ 27% vs 2022 (€ 460,730) Favourable step	€ 589,681 Equity 2024: € 589,681 ▲ 1% vs 2023 (€ 583,642) Favourable step	€ 652,568 Equity 2025: € 652,568 ▲ 11% vs 2024 (€ 589,681) Favourable step	▲ 11%
Total debts	€ 47,239 Total debts 2022: € 47,239 First fiscal year in the series	€ 18,159 Total debts 2023: € 18,159 ▼ 62% vs 2022 (€ 47,239) Favourable step	€ 185,401 Total debts 2024: € 185,401 ▲ € 167,242 vs 2023 (€ 18,159) Unfavourable step	€ 58,923 Total debts 2025: € 58,923 ▼ 68% vs 2024 (€ 185,401) Favourable step	▼ 68%
Cash	€ 206,228 Cash 2022: € 206,228 First fiscal year in the series	€ 117,054 Cash 2023: € 117,054 ▼ 43% vs 2022 (€ 206,228) Unfavourable step	€ 394,197 Cash 2024: € 394,197 ▲ 237% vs 2023 (€ 117,054) Favourable step	€ 139,184 Cash 2025: € 139,184 ▼ 65% vs 2024 (€ 394,197) Unfavourable step	▼ 65%
Land & buildings	€ 51,488 Land & buildings 2022: € 51,488 First fiscal year in the series	€ 46,646 Land & buildings 2023: € 46,646 ▼ 9% vs 2022 (€ 51,488) Unchanged	€ 41,804 Land & buildings 2024: € 41,804 ▼ 10% vs 2023 (€ 46,646) Unchanged	€ 36,962 Land & buildings 2025: € 36,962 ▼ 12% vs 2024 (€ 41,804) Unchanged	▼ 12%
Retained profit	€ 448,330 Retained profit 2022: € 448,330 First fiscal year in the series	€ 571,242 Retained profit 2023: € 571,242 ▲ 27% vs 2022 (€ 448,330) Favourable step	€ 577,281 Retained profit 2024: € 577,281 ▲ 1% vs 2023 (€ 571,242) Favourable step	€ 640,168 Retained profit 2025: € 640,168 ▲ 11% vs 2024 (€ 577,281) Favourable step	▲ 11%
Dividend	€ 0 Dividend 2022: € 0 First fiscal year in the series	€ 0 Dividend 2023: € 0 Unchanged (€ 0) Unchanged	€ 136,846 Dividend 2024: € 136,846 Unchanged (€ 0) Unchanged	€ 82,751 Dividend 2025: € 82,751 ▼ 40% vs 2024 (€ 136,846) Unchanged	▼ 40%
Bank debt	€ 0 Bank debt 2022: € 0 First fiscal year in the series	€ 0 Bank debt 2023: € 0 Unchanged (€ 0) Unchanged	€ 0 Bank debt 2024: € 0 Unchanged (€ 0) Unchanged	€ 3,361 Bank debt 2025: € 3,361 Unchanged (€ 0) Unfavourable step
Balance sheet total	€ 507,970 Balance sheet total 2022: € 507,970 First fiscal year in the series	€ 601,801 Balance sheet total 2023: € 601,801 ▲ 18% vs 2022 (€ 507,970) Unchanged	€ 775,082 Balance sheet total 2024: € 775,082 ▲ 29% vs 2023 (€ 601,801) Unchanged	€ 711,491 Balance sheet total 2025: € 711,491 ▼ 8% vs 2024 (€ 775,082) Unchanged	▼ 8%

By gross margin, VRICAN ranks 6th of 16 companies with main activity “Activiteiten van medisch specialisten” in Diest that publish figures (fiscal year 2025).

Key figures of VRICAN, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

Ask about VRICAN the way you would ask their accountant.

Answers from the filed annual accounts, the Belgian Official Gazette and the CBE register.

Connect ChatGPT or Claude for free

ChatGPT
Claude

Free account, no payment card. Key figures unlimited, the annual accounts and deeds of 10 companies a month. Need more? Get in touch, we are looking for our first pilot users.

What happened to VRICAN?

What happened at VRICAN in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Sep 30, 2026 New annual accounts for financial year 2025: profit of € 145,638 (▲ 2% vs 2024). filed late Source: NBB ↗
Jan 22, 2014 Capital increase of € 198,900, published in the Gazette. Source: Staatsblad ↗
Jan 23, 2006 Incorporation, published in the Gazette. Source: Staatsblad ↗
Jan 10, 2006 New establishment in Sint-Truiden. KBO
2005 David Van Roosbroeck became a director. NBB

In short

From € 93,766 profit in 2022 to € 145,638 profit in 2025.

Paid € 213,183 in corporate taxes since 2022.

Best year ever: 2025, with € 145,638 profit.

Paid out € 219,596 in dividends to the owners in total.

Original PDFs at the National Bank ↗

Management

David Van Roosbroeck

VRICAN

Behind VRICAN is David Van Roosbroeck.

Directors

According to the 2025 annual accounts

David Van Roosbroeck

Director

since 2005

Establishments

Establishment units

Physical locations of this company

Registered office

Refugiestraat 2

3290 Diest

2.250.245.194

Diestersteenweg 100

3800 Sint-Truiden

Active since 10 January 2006

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Similar companies in Diest

Same main activity (Activiteiten van medisch specialisten), 20 active companies in Diest, largest first.

Dr. Ilse Moortgat, oogarts

€ 700,876 gross margin · 2025

DR. CONINX

€ 582,956 gross margin · 2025

Dr. M. Koolen, Radiologie-Dr.S. Moreels, Cardiologie

€ 426,831 gross margin · 2026

CardioHub

€ 259,864 gross margin · 2025

Belgian Clinics

€ 250,534 gross margin · 2025

Dr. Meynen Femke - Reumatoloog

€ 203,678 gross margin · 2025

All companies with this activity → Largest companies in Diest →

Shareholders according to the Official Gazette deeds

Who contributed at incorporation and at capital increases, with the deed as source. Later share transfers are not published in the Gazette.

Incorporation

23 January 2006 Source: Deed ↗

VAN ROOSBROECK David Petrus Maria Carolus(enige oprichter) 100%

Details

Company number: 0878.611.053
VAT number: BE 0878.611.053
Registered office: Refugiestraat 2, 3290 Diest
Names & denominations: VRICAN
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 15 December 2005
Peppol: Active · Active since 16 Oct 2024
Activities · NACE: Activiteiten van medisch specialisten

View on CBE Public ↗ Annual accounts (NBB) ↗